AstraZeneca introduces combination drug Xigduo in UK for type 2 diabetes

AstraZeneca has launched its twice-daily tablet Xigduo (dapagliflozin and metformin hydrochloride in 5mg/850mg and 5mg/1000mg tablets) in the UK to treat patients with type 2 diabetes.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news